Subscribe To
Willow biosciences and suanfarma partner to develop large volume anti-infective api through precision fermentation
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has partnered with Spanish life science company Suanfarma to bring sustainably source...
October 3, 2023, 8:52 am
Eli lilly to buy point biopharma for $1.4 billion
Eli Lilly will acquire radiopharmaceutical company Point Biopharma Global for $12.50 a share....
October 3, 2023, 7:34 am
Regeneron, intellia therapeutics expand research collaboration to make gene editing therapies
Regeneron pharmaceuticals and Intellia Therapeutics have expanded their research collaboration to devel...
October 3, 2023, 7:10 am
First wave biopharma ceo james sapirstein to present at the 2023 roth healthcare opportunities conference
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a c...
October 3, 2023, 7:00 am
Acumen pharmaceuticals: novel alzheimer's molecule with positive early data
Acumen pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers...
October 3, 2023, 5:15 am
Synairgen hires full-time chief medical officer as drug development ramps up
Synairgen PLC (AIM:SNG, OTC:SYGGF) has appointed seasoned pharmaceutical physician and drug developer D...
October 3, 2023, 2:27 am
Bragar eagel & squire, p.c. reminds investors that class action lawsuits have been filed against applied digital, infinity, and shift4 and encourages investors to contact the firm
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that ...
October 3, 2023, 1:00 am
Takeda announces voluntary withdrawal of lung cancer therapy
Takeda pharmaceutical said on Monday it would be working with the U.S. health regulator towards a volun...
October 2, 2023, 5:13 pm
Syros pharmaceuticals undergoes leadership shakeup, workforce reduction
Syros pharmaceuticals shares dropped on Monday after a series of shakeups at the biotech company. The f...
October 2, 2023, 4:09 pm
Clade therapeutics announces the acquisition of gadeta b.v.
Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform technology,– g/d TCR ca...
October 2, 2023, 12:30 pm
Ups to gain from mnx global logistics buyout: here's how
The acquisition will bring MNX Global Logistics' potential in radio-pharmaceuticals and temperature-con...
October 2, 2023, 11:16 am
2 cathie wood stocks that could deliver exponential returns
Cathie Wood is a thematic investor focused on disruptive new technologies. Recursion pharmaceuticals co...
October 2, 2023, 10:45 am
Cellectar biosciences expands global intellectual property portfolio with four patent grants
FLORHAM PARK, N.J., Oct. 02, 2023 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical bio...
October 2, 2023, 10:35 am
Syndax pharmaceuticals fall despite positive leukemia
Syndax pharmaceuticals (NASDAQ:SNDX) Inc (Syndax pharmaceutical...
October 2, 2023, 9:22 am
Novabay pharmaceuticals to present at the dawson james small cap growth conference
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay pharmaceuticals, Inc. (NYSE American: NBY), a company deve...
October 2, 2023, 6:50 am
Smiledirectclub shares plunge after bankruptcy filing, with syndax and amc shares climbing and other active stocks
Syndax pharmaceuticals Inc. SNDX, -7.10% rose 19% in premarket trading. The clinical stage bio...
October 2, 2023, 5:41 am
Futura medical shares up on patent news - interesting at these levels, says bank
Futura Medical PLC (AIM:FUM, OTC:FAMDF), a pharmaceutical company specialising in sexual health product...
October 2, 2023, 3:57 am
Drugmaker viatris to divest some of its businesses
Drugmaker Viatris said on Sunday that it has entered into agreements to divest its businesses, including the Women's Healthcare business and its Activ...
October 1, 2023, 5:18 pm
Kalvista's sebetralstat: a pill worth swallowing in hae
KalVista pharmaceuticals is positioned to disrupt the HAE treatment landscape with its oral therapy, se...
October 1, 2023, 12:05 am
Apls deadline alert: rosen, a leading law firm, encourages apellis pharmaceuticals, inc. investors with losses in excess of $100k to secure counsel before important october 2 deadline in securities cl
NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Apellis ...
September 30, 2023, 8:46 pm